Second, although previous studies have shown serotonin can influence the immune microenvironment of tumors, and YIF1B could influence the immune status of cancer patients by interfering with serotonin signaling, direct experimental demonstration of an effect of YIF1B on the immune microenvironment of a tumor is needed. This evidence concerns the gene YIF1B and neoplasm.